29.1.2013
•
News
Three KŠB Experts Listed in the Latest Issue of Who´s Who Legal
Renowned British rating agency Who’s Who Legal, which has recommended the foremost legal practitioners in 32 categories in over 100 countries worldwide since 1996, lists three KŠB experts in its latest guide.
KŠB tax partner Helena Navrátilová was recommended as one of two Czech experts in corporate tax. In the competition law category, KŠB partner Pavel Dejl was named a leading competition expert in the Czech Republic. And finally, Jiří Horník, also a KŠB partner, was listed as an aviation expert. Jiří was also one of four leading experts invited by Who’s Who Legal to give an interview on hot aviation topics such as alternative financing methods, changing regulations, and increasing competition on the market.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
